Search results

Jeff Plomley discusses how patient-centric blood microsampling can enable at-home, minimally invasive sample collection, and improve accessibility and clinical trial efficiency.

Julie Forget reflects on the ACT Annual Meeting, highlighting cutting-edge toxicology research, gene therapy trends, and the strong sense of scientific community.

Explore dose range finding (DRF) studies in nonclinical research, from safety assessments to pharmacokinetics and biomarkers, ensuring optimized drug development.